Approvals/CIMA-AEMPS/ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Approved

STANDARD

ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c6de817e256b3282
Drug Cima Aemps Name: ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)
Register Number: 114898002IP3
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-08-08
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 55 MICROGRAMOS/22 MICROGRAMOS
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 8, 2025

Approval ID

c6de817e256b3282

Type

Standard